Home / Share Price Target / Gland
Gland Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
Gland Pharma Limited | |||
 | Symbol: GLAND | ||
| Price: ₹1,755.05 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - General | |||
Show Table of Contents
Table of Contents
- 1: Gland Pharma Brief Company Overview
- 1.1: Company Overview of Gland Pharma Limited
- 1.2: Gland Pharma Financial Performance
- 1.2.1: Is Gland Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Gland Pharma Share Price Target For 2024
- 2.1.1: Gland Pharma Share Price Target Table For 2024
- 2.1.2: Summary: Gland Pharma Share Price Prediction For 2024
- 2.2: Gland Pharma Share Price Target For 2025
- 2.2.1: Gland Pharma Share Price Target Table For 2025
- 2.2.2: Summary: Gland Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Gland Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Gland Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Gland Pharma Past Performance
Gland Pharma Brief Company Overview
Company Overview of Gland Pharma Limited
Gland Pharma Limited, a pioneer in the pharmaceutical industry since 1978, is renowned for its expertise in manufacturing and distributing injectable formulations globally. Headquartered in Hyderabad, India, and backed by the strength of Fosun Pharma Industrial Pte. Ltd., Gland Pharma caters to a diverse range of markets, including the United States, Europe, Canada, and Australia.
Their commitment to innovation is evident in their robust research and development initiatives, focused on pharmaceutical API products, including the synthesis of complex drug molecules. Gland Pharma offers a comprehensive portfolio of products spanning various therapeutic categories, meeting the needs of patients across the globe.
Key Products and Services:
- Injectable formulations
- Pharmaceutical API products
- Contract development services
Market Presence:
- India
- United States
- Europe
- Canada
- Australia
- New Zealand
- International
Reputation: Gland Pharma Limited has consistently maintained a stellar reputation in the industry, recognized for its quality products, commitment to innovation, and customer-centric approach.
Gland Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 29,286.31 Crore | Market valuation of Gland Pharma's shares. |
| Revenue (TTM) | 5,890.14 Crore | Total revenue generated by Gland Pharma over the past twelve months. |
| Net Income (TTM) | +691.56 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 14.45% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 11.74% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +2.4% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | -15.7% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 3.71 | Company's total debt divided by total shareholder equity. |
| Total Debt | 326.62 Crore | Sum of Gland Pharma's current & long-term financial obligations. |
| Total Cash | 2,820.1 Crore | Total amount of liquid funds available to Gland Pharma. |
| Beta | 0.33 | Beta is less than 1 indicating that the Gland Pharma's price is less volatile than the market. |
Is Gland Pharma A Good Buy For Long Term?
Gland Pharma, a large-cap stock with a market capitalization of ₹29,227 crore, presents a mixed picture for long-term investors. While its ₹2,820.1 crore cash balance is positive, a 15.7% year-on-year decline in Q2 2024-25 earnings and a negative 3-year return (-24.18%) raise concerns. Although the 11.74% profit margin is decent, the recent past performance ( -17.17% in 3 months, -7.83% YTD) suggests caution. Overall, Gland Pharma is currently an average buy for the long term; further analysis and market trend monitoring are recommended before making an investment decision.
To predict the Gland Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Gland Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Gland Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Gland Pharma shares in 2024, see the table below.
Gland Pharma Share Price Target Table For 2024
| Gland Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 1836.06 (+4.61%) | Technical Indicator: MA150 |
| 2024 Target 2 | 1817.70 (+3.56%) | Price Action: Nov 2023 High |
| 2024 Target 1 | 1798.09 (+2.45%) | Price Action: 19 Nov 2024 High |
| Current Price | 1755.05 | Gland Pharma's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 1780.00 (+1.42%) | Price Action: 11 Nov 2024 Low |
| Stop Loss 2 | 1759.50 (+0.25%) | Fibonacci Retracement Level 50% |
| Stop Loss 3 | 1740.90 (-0.81%) | Price Action: Apr 2024 High |
Summary: Gland Pharma Share Price Prediction For 2024
In summary, Gland Pharma has declined by ₹-169.45, recording a notable -8.80% decrease from 1st January 2024 to 22 Nov 2024. Despite the setback, our analysis of Gland Pharma for 2024 predicts an additional rise of 2.45% to 4.61% by the end of 2024 with three potential targets T1: 1798.09, T2: 1817.70, T3: 1836.06. Stop Loss at SL1: 1780.00, SL2: 1759.50, SL3: 1740.90.
Gland Pharma has a 52-week high of ₹2220.94, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1585.69, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Gland Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Gland Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Gland Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Gland Pharma shares in 2025, see the table below.
Gland Pharma Share Price Target Table For 2025
| Gland Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 2311.63 (+31.71%) | Price Action: Chart |
| 2025 Target 2 | 2268.53 (+29.25%) | Price Action: Chart |
| 2025 Target 1 | 2246.07 (+27.97%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 1755.05 | Gland Pharma's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 1680.00 (-4.28%) | Price Action: Oct 2022 Low |
| Stop Loss 2 | 1662.15 (-5.3%) | Price Action: 21 Oct 2024 Low |
| Stop Loss 3 | 1640.00 (-6.56%) | Price Action: 22 Oct 2024 Low |
Summary: Gland Pharma Share Price Prediction For 2025
In summary, Gland Pharma has declined by ₹-169.45, recording a notable -8.80% decrease from 1st January 2024 to 22 Nov 2024. Despite the setback, our analysis of Gland Pharma for 2025 predicts an additional rise of 27.97% to 31.71% by the end of 2025 with three potential targets T1: 2246.07, T2: 2268.53, T3: 2311.63. Stop Loss at SL1: 1680.00, SL2: 1662.15, SL3: 1640.00.
Gland Pharma has a All-Time high of ₹4350.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1585.69, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Gland Pharma, we have created a specific page for that check here: Gland Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Gland Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Gland Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of -2.25% over the next 15 years.
For complete year by year Gland Pharma long term share price target from 2024, 2025 to 2039 check the below table.
Gland Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Gland Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹1,755.05 | [Current Price] |
| 2024 | ₹1,757.65 | 0.14% |
| 2025 | ₹1,665.75 | -5.23% |
| 2026 | ₹1,603.37 | -3.75% |
| 2027 | ₹1,443.4 | -9.98% |
| 2028 | ₹1,446.8 | 0.23% |
| 2029 | ₹1,352.04 | -6.55% |
| 2030 | ₹1,262.75 | -6.61% |
| 2031 | ₹1,195.73 | -5.31% |
| 2032 | ₹1,413.64 | 18.22% |
| 2033 | ₹1,457.47 | 3.1% |
| 2034 | ₹1,404.39 | -3.65% |
| 2035 | ₹1,351.98 | -3.74% |
| 2036 | ₹1,332.34 | -1.46% |
| 2037 | ₹1,226.17 | -7.97% |
| 2038 | ₹1,258.92 | 2.67% |
| 2039 | ₹1,277.33 | 1.46% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Gland Pharma Past Performance
- In 2020, Gland Pharma opening price was ₹2,120
- As of Fri 22 Nov 2024 the price stands at ₹1,755.05.
- This represents a Compound Annual Growth Rate (CAGR) of -3.71%.
- In 4 years, an investment of 10,000 would have become ₹8,278.53.
As we wrap up, we hope you like our study on Gland Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
